FF and in culture media at each step of IVF undergone by HCV + women; (ii) investigate the impact of blood contamination of FF induced by vascular injury associated with transvaginal ovarian puncture; (iii) assess risk for the embryo and the impact on the contamination rate of the newborn; and (iv) determine the viral risk presented by these¯uids in order to de®ne guidelines for the laboratory. METHODS: FF from 22 IVF procedures performed in 17 HCV + women were classi®ed as either clear, lightly bloody or bloody FF. Oocytes from each FF were washed and incubated in separated fertilization media. At 20 h after puncture (day 1), the fertilized oocytes were washed and transferred to fresh media until embryo transfer. HCV RNA was detected and quanti®ed in FF and media using Cobas Amplicor and Cobas Monitor HCV RNA kits. RESULTS: HCV RNA was positive in 39 of 44 FF samples, and viral loads increased with blood contamination. At day 1, after rinsing of oocyte±cumulus complexes, only 8 of 44 media were still positive. Viral loads were quanti®ed in 5 of 8 positive media, were below the test sensitivity threshold in 4 of 5 HCV RNApositive media, and just above it in the ®fth medium. The day of transfer HCV RNA was undetectable in all media. CONCLUSIONS: HCV RNA was detected in 89% of FF irrespective of the degree of blood contamination, and in 25% of the media at day1. FF must be considered as potentially infected. Blood contamination increases HCV load in the FF. Rinsing oocytes seems signi®cantly to discard the HCV RNA. It is too early to assess the impact of IVF on the contamination rate of HCV mothers' offspring. After counselling, attempting IVF in HCV + women is justi®ed. Universal guidelines prevent nosocomial infection, and IVF does not speci®cally increase the professional risk.
Introduction
Questions concerning contamination and the transmission of infections have been raised since the inception of IVF. Various bacteria and viruses have been incriminated, including Chlamydia trachomatis, cytomegalovirus (CMV), hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunode®ciency virus (HIV). In France, the prevalence of HCV is approximately 1.15% (Roudot-Thoraval et al., 1996; Dubois et al., 1997) . In these studies, the origin of contamination was essentially due to parenteral exposure (65% of cases), and sexual transmission was considered to be very rare (1.2% of cases). Moreover, mother-to-child viral transmission has been estimated to range from 5 to 10% depending on the viral load of the maternal serum (Ohto et al., 1994; Poiraud et al., 2001 ).
Despite these reassuring results, assisted reproductive techniques (ART) have only been permitted in France for infertile HCV + couples since 1999 (Arre Ãte Â du 12 Janvier, 1999). The mechanism through which HCV infection favours vertical transmission of the virus is still not fully understood. Little information is available about the moment when HCV motherto-child transmission occurs, and no procedure to reduce transmission rates has been identi®ed (Yeung et al., 2001) . Although the presence of HCV in sperm is well established (Leruez-Ville et al., 2000; Levy et al., 2000; Pasquier et al., 2000; Cassuto et al., 2002) , until now, apart from two French preliminary studies (Devaux et al., 2001; Leruez-Ville et al., 2001) , no reports have been made concerning the detection of HCV in follicular¯uid (FF) obtained during ovarian puncture in the IVF procedure. Transvaginal ovarian puncture is always associated with some form of vascular injury, and might lead to the induction of HCV + blood contamination of the FF. The impact of this occurrence on the viral contamination risk for gametes and embryos is ignored, however. Although some ART professionals propose that oocytes from bloody FF be discarded (National Conference of ART French biologists, 2000; unpublished data) , this attitude might affect IVF outcome. The possibility that ART could increase the HCV + mother-to-child contamination rate or could induce a viral risk for embryos of non-infected couples and for laboratory workers, explains why in France infertile HCV carriers have not been accepted for IVF. In order to evaluate the impact of ART on the contamination rate of offspring, a national followup case±control study on HCV + mothers' offspring, born after IVF and compared with spontaneous pregnancy, is on-going (Protocol ANRS HC 04, Roudot-Thoraval, 2000) . The intent of this prospective protocol was an analysis of the transmission rate for 400 children from each group.
In this context, the study aim was to: (i) search for HCV RNA in FF and in culture media at each step of IVF undergone by HCV + women; (ii) investigate the impact of blood contamination of the FF induced by vascular injury associated with the transvaginal ovarian puncture; (iii) evaluate the risk for the embryo and the impact on the contamination rate of the newborn; and (iv) determine the viral risk presented by thesē uids, in order to de®ne guidelines in the laboratory.
Materials and methods

Patients
Seventeen couples in which the women were HCV + were enrolled in the study, and IVF was attempted 22 times. All the women presented with active HCV viral replication detected in blood before ART, but were negative for HIV. A total of 21 embryo transfers was performed. Two couples who were negative for both HCV and HIV constituted the control group for the viral tests. None of the HCV carrier women had received any antiviral treatment during the 7 months preceding their inclusion into the authors' ART centre. All male partners were HCV negative. The origin of HCV contamination was professional in two cases (11.8%), following blood transfusion in two cases (11.8%), due to intravenous drug addiction in four cases (23.5%) and unknown in nine cases (52.9%).
The median age of the women was 37.5 (range 29±43) years, and 10 of them were aged over 38 years (59%). Causes of infertility were Fallopian tube disease (n = 11), dysovulation (n = 1), mixed (n = 3) and undetermined (n = 2).
Sample collection
Samples were collected during 22 conventional IVF attempts. On day 0, at 36±37 h after hCG administration, FF containing oocyte±cumulus complexes were recovered by transvaginal ultrasound-guided needle aspiration using a prewarmed syringe. Syringes were classi®ed and pooled depending on the macroscopic blood contamination; they were labelled A0 when FF was clear, A1 when FF was lightly coloured, and A2 for bloody FF. Oocyte collection and identi®cation were carried out using a stereomicroscope equipped with a warm working area (37°C). Once identi®ed, oocyte±cumulus complexes were rinsed several times and incubated in new multi-well dishes containing prewarmed B2 Upgraded Medium (INRA, CCD, France) labelled B0, B1, B2 depending on the macroscopic blood contamination of FF. Samples A0, A1 and A2 of FF were stored at ±80°C until the viral tests. The selected oocytes were inseminated with prepared spermatozoa for the fertilization step and stored at 37°C under 5% CO 2 .
At 17±19 h after insemination (day 1), all oocytes were transferred from B0, B1 and B2 into new multi-well dishes containing prewarmed B2 Upgraded Medium. Granulosa cells surrounding oocytes were removed. Samples of B0, B1 and B2¯uids were stored at ±80°C until the viral tests. Oocytes were checked for maturity and evidence of normal fertilization (two pronuclear). Fertilized oocytes were rinsed again and transferred into new multi-well dishes of fresh prewarmed medium labelled C0, C1 and C2, depending on the origin of the oocytes.
At 48 or 72 h after insemination (day 2 or 3), embryo development (cell number and degree of fragmentation) was recorded. Two or a maximum of three embryos were transferred, while excess embryos were cryopreserved in liquid nitrogen. Samples of C0, C1 and C2 uids were stored at ±80°C until the viral analysis. Three types of FF were collected (A0, A1, A2) in six of the 21 IVF procedures, but only two of the three FF types were collected in 11 of 21 IVF procedures. Only bloody FF (A2) was collected in four IVF procedures. A total of 153 samples was collected, including blood plasma (n = 24), A0 (n = 17), A1 (n = 15), A2 (n = 15), B0 (n = 17), B1 (n = 15), B2 (n = 15), C0 (n = 15), C1 (n = 12) and C2 (n = 8).
Viral tests
HCV RNA was detected using a reverse transcription PCR assay in plasma, FF and in the different media collected at each IVF step. Assays were carried out using the same commercial kit as for serum or plasma and according to the manufacturer's instructions (Cobas Amplicor HCV 2.0; Roche, Meylan, France). Plasma and FF were tested undiluted; the sensitivity of the method was 0.05Q10 3 IU/ml. When the available volume of culture media at day 1, 2 or 3 was insuf®cient, the samples were diluted 1:2 before being tested; the sensitivity in these cases was 0.1Q10 3 IU/ml. Two methods were used to control the results. Uracil DNA glycosylase was included for prevention of false-positive results, while false-negative results due to Taq inhibitors were evaluated by use of an internal control introduced into each sample, co-extracted and co-ampli®ed with target RNA (Amplicor Internal Control Detection Kit; Roche). When HCV RNA was detected in a sample, quanti®cation was performed using a Cobas Monitor HCV RNA kit (Roche). In the ®rst batch of tested samples, Taq inhibitors were present once in FF during qualitative detection and four times in FF and culture media during quantitative tests. These samples were submitted to high-speed centrifugation (23 500Qg for 1 h at 4°C) before extraction, and then tested using the same protocol as described above. No inhibitor was found after this procedure. Subsequently, all samples except plasma were centrifuged before extraction and no inhibitor was detected.
Statistical analysis
As HCV load data in the samples could clearly not be considered as Gaussian, all analyses were based on non-parametric rank statistics and tests. The association between HCV load in FF and in the serum was assessed through Spearman's correlation coef®cient, separately for A0, A1 and A2. FF HCV loads were compared according to the bloody status using Friedman's two-way analysis of variance, the subject being the blocking factor, in order to account for nonindependence between measures on the same subject. This test compared the three groups. However, to identify where the difference was post-hoc, a 2Q2 comparison was performed using Wilcoxon's signed rank sum test for paired data, with Bonferroni's correction for multiple testing to guarantee a global type 1 error risk at 0.05. The frequency of patients with detectable HCV load in FF, and after oocyte washing in B0, B1 and B2 collected at day 1, was compared using McNemar's test. All tests were two-sided, with a P-value of 0.05 being considered statistically signi®cant. Analyses were performed using SAS v8.2 (SAS Institute, Cary, NC, USA) and S-Plus 2000 (Mathsoft Inc., Seattle, WA, USA) software. For the analyses (see Table III ), when the qualitative detection was negative (below the 100 IU/ml threshold), the value was noted zero (`0'); when the qualitative detection was positive with a quantitative detection below the 0.6Q10 3 IU/ml threshold, a value of 0.5Q10 3 IU/ml was arbitrarily attributed.
Results
HCV RNA detection
HCV RNA was negative in all samples of the group of HCV ± women. In one of the 17 HCV + women, viral detection was negative in the blood on the day of ovarian puncture and in all other samples collected for this patient.
HCV RNA detection was positive in the other 16 sera samples on the day of ovarian puncture. A total of 140 samples was collected from these 16 HCV + women and analysed during 21 IVF procedures (Table I) . A total of 44 FF samples was tested, with HCV RNA detection being positive in 13 of 14 A0 (93%), 12 of 15 A1 (80%) and 14 of 15 A2 (93%). At day 1, HCV RNA was positive in 1 of 14 B0 (7%), 2 of 15 B1 (7%) and 5 of 15 B2 (47%); negative in 11 of 14 B0 (79%), 12 of 15 B1 (80%) and 8 of 15 B2 (53%), and doubtful in two B0, one B1 and two B2. On the day of embryo transfer, all the tested samples C0, C1 and C2 were negative. HCV RNA detection was positive in 89% of all FF samples (39/44), irrespective of the degree of macroscopic blood contamination, but was negative in one A0, two A1 and one A2, even though it was positive in the corresponding serum sample. Rinsing of the oocyte±cumulus complexes before transfer into the culture media on the day of ovarian puncture, and a second rinsing after checking of pronuclear status at day 1, reduced the detection of HCV RNA (B0, B1 and B2) which became undetectable at the day of embryo transfer in all media (C0, C1 and C2).
HCV RNA quanti®cation
Eighteen of 21 serum samples from 16 HCV + positive women were tested on the day of ovarian puncture (in three cases there was insuf®cient serum for quanti®cation) (Table II) . Serum virus loads ranged from 1.2Q10 3 to 9.96Q10 6 IU/ml. In only one case was quanti®cation below the test sensitivity (threshold = 0.6Q10 3 IU/ml). In this case, the serum load was between 0.05Q10 3 IU/ml (threshold of qualitative detection in serum) and 0.6Q10 3 IU/ml (threshold of quantitative detection).
Thirty-seven out of 39 HCV RNA-positive FF were quanti®ed (13 A0, 12 A1 and 12 A2), the volume available for analysis being insuf®cient in two A2 samples. The virus load was below the threshold in 9 of 13 A0 (69%), in 3 of 12 A1 (25%) and in 1 of 12 A2 (8%).
HCV RNA was quanti®ed in ®ve of eight positive culture media (one B0, one B1, three B2). For the other three HCV RNA-positive samples (one B1, two B2) and for the ®ve qualitatively doubtful samples (two B0, one B1, two B2) the available volume was insuf®cient. The virus load was below threshold (600 IU/ml) in four of ®ve cases, and just above it in the last sample (608 IU/ml).
The virus load increased with the degree of macroscopic blood contamination (see Table III ). In 13 of 39 FF samples (33%), the HCV RNA quanti®cation was <0.6Q10 3 IU/ml, a The values 0, 1 and 2 refer to the degree of blood contamination of the original follicular aspirates. d = doubtful; nv = not suf®cient volume available; ns = no sample collected. + = positive HCV RNA qualitative detection; ± = negative HCV RNA qualitative detection. Samples: A = follicular¯uid; B = culture media collected at day 1; C= embryo culture medium.
while in the other samples the virus load ranged from 2.84 to 325.0Q10 3 IU/ml. There was a signi®cant correlation between HCV serum load and HCV FF load (r = 0.64, P = 0.033 for A0; r = 0.92, P = 0.0014 for A1; and r = 0.65, P = 0.032 for A2).
Friedman's two-way analysis of variance yielded a signi®cant FF bloody status effect (P = 0.016), thus indicating that the FF HCV load differed according to the FF blood contamination status. Post-hoc comparisons gave the following P-values: P = 0.016 for A0 versus A2; P = 0.023 for A1 versus A2; and P = 0.12 for A0 versus A1. When applying a full Bonferroni's correction, the signi®cance level had to be taken at 0.017 to account for multiplicity of tests, yielding a signi®cant difference only between A0 and A2. However, this comparison between A0 and A1, A0 and A2, A1 and A2 was limited respectively to 11, seven and seven pairs of samples.
The frequency of samples with detectable HCV load was signi®cantly higher before (A0, A1, A2) than after oocyte washing (B0, B1 and B2), as shown by McNemar's test (P < 0.0001). HCV RNA detection was always negative in C0, C1 and C2. Rinsing appeared effectively to reduce the HCV load in the culture media.
IVF outcome
Twenty-two conventional IVF were performed, and 21 embryo transfers were made. In total, six pregnancies were obtained (®ve singles, one twin), four deliveries and ®ve newborn. In two of the single pregnancies and in the twin pregnancy with a normal delivery, four babies remained HCV RNA PCRnegative at 6 months after birth. In one case the mother developed an acute hepatitis with an increasing HCV RNA load at 7 months gestation. A non-scheduled Caesarean for a Values 0, 1 and 2 refer to the degree of blood contamination of the original follicular¯uid aspirates. *Value selected when the qualitative detection was positive and quantitative detection was under the threshold of 600 IU/ml. **Value selected when qualitative detection was negative (threshold = 100 IU/ml). FF = follicular¯uid.
HCV in follicular¯uid and culture media in IVF single premature baby was performed at 8 months; HCV RNA detection by PCR assay was positive in the infant at 6 months after birth. Control investigations will be made at 12 months after the birth, and two pregnancies are still on-going.
Discussion
With regard to the ®ndings of these studies, several points require discussion, including the detection and localization of HCV RNA, the viral risk occurring during IVF, and the impact of ART on mother-to-child transmission.
HCV RNA detection
Using the present technique, HCV RNA can be clearly identi®ed in FF (A0, A1, A2) and in culture media (B0, B1, B2), and this con®rms the present authors' initial results (Devaux et al., 2001) . No PCR inhibitor was detected in any of the samples. HCV RNA has been detected in a variety of body secretions (Liou et al., 1992; Tang et al., 1996; Ackerman et al., 1998) , but not in saliva (Fried et al., 1992) , though the latter study was conducted in only nine patients. More recently, HCV RNA was detected in 33% of saliva samples (Kage et al., 1997) and in 36% of normal cervical smears of viraemic women (Manavi et al., 2002) . Contradictory results have also been obtained in colostrum and breast milk. In colostrum, a 10% positive detection was reported (Aizaki et al., 1996; Morales et al., 1996) , despite the viral load being very low in one study (Hunt et al., 1997) and even negative in others (Kage et al., 1997; Polywka et al., 1997) . In a prospective study of 16 HCV + women, HCV RNA was detected in only one sample of clear amniotic¯uid (Delamarre et al., 1999) . Although in earlier studies HCV could not be detected in sperm samples from HCV + men (Semprini et al., 1998; Debono et al., 2000) , more recent investigations have shown HCV to be present in 5±10% of sperm samples analysed (Leruez-Ville et al., 2000; Levy et al., 2000; Pasquier et al., 2000; Cassuto et al., 2002) . HCV RNA detection methods and the low number of samples tested might provide an explanation for these contradictory results (Bourlet et al., 2003) . In the present study, the use of uracil DNA glycosylase and an internal control prevented false responses. In order to be considered as infectious, FF must present infectious characteristics. Although the present viral tests were based on particles of genome detection after RNA ampli®cation, this technique reveals the presence of virus genomes, but not their infectivity (Dore, 2000) . It is unclear whether the viral particles in FF have an infectious nature, and as HCV culture is dif®cult to perform in vitro there are at present no data available to answer this question. Hence, at present it is impossible to evaluate precisely the viral risk presented by FF. Nevertheless, because HCV RNA was detected in most of the follicular aspirates, FF aspirated in HCV + women should be considered as potentially infected, irrespective of the degree of macroscopic blood contamination. This observation raises some questions about the original HCV localization inside the follicle in vivo, or to what extent this was induced by the ovarian puncture.
Origin of HCV in follicular¯uid
In order to evaluate the viral risk induced by ART and to inform the couples, knowledge is required of the localization of the virus in vivo. Follicular¯uid cannot be collected without follicle rupture, and this might involve a risk of contamination as a result of vascular injury occurring during the ovarian puncture.
HCV RNA was not detected in four FF samples, but might have been undetectable as three of these HCV + women had viral replication (Table II: patients 3, 6 and 11) and one showed no HCV replication (patient 17). If HCV penetrates inside the follicle in vivo, its load is likely to be very low and below the viral test threshold. FF is secreted by granulosa cells. In the ovary, a thick basement membrane surrounds the follicle and separates granulosa cells and the surrounding stromal cells which form a layer containing the vessels with ill-de®ned outer limits called the theca folliculi. Until ovulation, this membrane separates the follicle components and the vessels. The basement membrane is considered to be a barrier which protects the follicle and principally the oocyte (Bloom and Fawcett, 1986) . No data are available concerning the possible compartmentalization of HCV in the follicle in vivo. However, a compartmentalization might be evoked in both the male genital tract (Leruez-Ville et al., 2000; Pasquier et al., 2000; Cassuto et al., 2002) and amniotic¯uid (Delamarre et al., 1999) .
Cytological FF analysis has shown the constant presence of peripheral cells (lymphocytes, granulocytes and erythrocytes) (unpublished data), and this provides proof of the constant association of blood contamination with the puncture. Viral loads increase signi®cantly with the presence of macroscopic blood contamination. A similar study on 33 clear amniotic¯uid samples from 22 HCV + women showed that HCV RNA could also be detected in one of 16 viraemic women (Delamarre et al., 1999) . These authors invoked the impact of amniotic puncture on the contamination of amniotic¯uids. In IVF, the high HCV RNA detection rate in FF (89%) can most likely be explained by the vessel injuries associated with ovarian puncture.
In conclusion, the presence of HCV was highly unlikely in the ovarian follicles in vivo, but when it did occur it was below the threshold of the present technique. HCV RNA detection appears to be induced by vascular injuries that are always associated with ovarian puncture, and the possible consequences of this blood contamination must be considered.
Viral risk for oocytes and embryos
As HCV RNA was detected in 89% of FF samples, all FF samples should be considered as potentially infected, and consequently the viral risk for retrieved follicles must also be considered. Following ovarian puncture, FF is retrieved which contains oocytes surrounded by granulosa cells. Two HCV receptors for HCV have been identi®ed, namely the CD 81 molecule and the low-density lipoprotein receptor (rLDL) (Pileri et al., 1998; Flint et al., 1999; Germi et al., 2001) , the rLDL having been reported present on granulosa cells (La Voie et al., 1999) . The possible adsorption of HCV onto granulosa cells during ovarian puncture cannot be eliminated.
Consequently, HCV present as a result of blood contamination might also be adsorbed onto the granulosa cells, and this might explain the presence of HCV RNA in spite of the ®rst follicle washing. HCV RNA was never detected in the embryo culture media after washing, removal of granulosa cells and refreshing the culture mediaÐa result which seems to indicate that HCV RNA might be adsorbed onto granulosa cells in FF during the IVF procedure, though further studies are needed to verify this hypothesis. Furthermore, until implantation the oocytes and embryos are surrounded by the zona pellucida (ZP), which is considered to be a physiological protective barrier. Evaluation of the viral risk for oocyte and embryo during IVF has not yet been completely de®ned, though it cannot be ignored and deserves future study. However, whilst awaiting further information this risk can be evaluated indirectly by monitoring the contamination rate of the offspring after IVF compared with spontaneous pregnancies in HCV + women.
Impact on contamination of the offspring
Although vertical mother-to-infant HCV transmission in spontaneous pregnancy has been well documented (Tibbs, 1995; Dienstag, 1997; Hunt et al., 1997; Michielsen and Van Damme, 1999; Yeung et al., 2001) , the mode and moment of transmission are not well known. The transmission rate was only 6% in patients with a viraemia below 10 6 copies/ml (Poiraud et al., 2001) , and contamination occurred most frequently at the time of delivery (Abergel et al., 1995; Moriya et al., 1995; Sabatino et al., 1996) . Hepatitis C appears to have no impact on pregnancy and fetal development (Marcellin et al., 1993) . However, acute hepatitis C contracted during the third trimester of pregnancy might induce contamination of the child (Hunt et al., 1997) , and 50% of children infected present with a clinical infection, though this is usually benign. Pregnancy has never been contraindicated in HCV + women.
In the present study, the HCV RNA titre was >10 6 IU/ml in four of 16 serum samples, but never reached this level in FF samples. After washing and refreshing the culture media, HCV RNA decreased and was apparently discarded in the embryo media. The viral risk which could be induced by IVF procedures appeared to be low. A total of 21 embryo transfers was performed in 16 women, from which six pregnancies were obtained with ®ve newborns (four HCV-negative and one HCV-positive). In the latter case the mother had developed acute hepatitis during the third trimester of pregnancy, the serum viral load had increased from 1.9Q10 6 to 15.3Q10 6 copies/ml, and the delivery was a non-scheduled Caesarean. A viral load beyond 10 6 copies/ml leads to contamination of the child in 50% of cases (Ohto et al., 1994; Lin et al., 1994) . Moreover, HCV RNA detection was negative in the amniotic uid sampled for prenatal diagnosis, which would suggest that contamination on delivery and the impact of amniotic puncture must be further studied.
At present, the number of newborn babies is too small to evaluate whether IVF either decreases, increases or does not modify offspring contamination rate. In France, a national follow-up case±control study on the offspring of HCV + mothers after IVF compared with spontaneous pregnancy is on-going (Protocol ANRS HC 04, Roudot-Thoraval, 2000) . The follow-up involves 400 children for each group at 3, 6 and 12 months after birth. After 140 IVF procedures performed in France, 25 pregnancies were obtained with 12 HCV-negative babies and one PCR-positive baby (Devaux and RoudotThoraval, 2002) . Half of the pregnancies in these preliminary results were obtained at the present authors' centre, and the other pregnancies are still on-going.
HCV undergoes very rapid mutation. Hence, in order to determine the time at which the child is contaminated, HCV sequencing should be conducted on the maternal blood (which is stored on the day of puncture) as well as on the infected infant's blood.
HCV and guidelines for IVF centres
The risk of nosocomial infection in ART has been discussed (Botta-Fridlund, 1994; McKee et al., 1996; Steayert et al., 2000) . Two cases of HCV nosocomial infection have been described during ancillary procedures for ART (Lesourd et al., 2000) . Although such contamination has occurred in the operating theatre, until now it has never been described in an IVF laboratory. Two types of risk in the laboratory must be considered, namely contamination of the HCV ± couple's embryos, and contamination of laboratory workers during ART. In this respect, the high prevalence of hepatitis C (as mentioned above) must be taken into account, as well as the high detection rate of HCV RNA in FF, and hence all FF samples should be considered as potentially contaminated. Strict adhesion to universal guidelines (CDC Atlanta NMWR no. 2, 1987) can prevent gamete and embryo contamination of HCV ± couples. Moreover, in France speci®c statements have been prepared for IVF laboratories that perform ART in a viral context (Arre Ãte Â du 10 Mai, 2001). A separation of the IVF procedures for carrier and non-carrier virus couples (for HIV, HCV and HBV) in time or in space must be respected. In addition, the cryopreservation of embryos must be carried out in high-security straws which are stored in a speci®c liquid nitrogen tank. However, this procedure goes against the universal laboratory guidelines, where all samples must be considered as potentially infected and no speci®c circuit is organized. These speci®c laboratory procedures, which have been in operation in France since 1999 (Arre Ãte Â du 12 Janvier, 1999), should be discussed when the impact of ART on embryo viral contamination risk is to be assessed. Until such discussion has been concluded, all FF must be considered as potentially infected and treated according to the laws in France.
Discarding oocytes from bloody FF, as has been proposed by some practitioners in order to prevent a viral risk, appears unnecessary. This procedure might affect IVF outcome by decreasing the number of oocytes for the fertilization step. During the IVF procedure, the decreasing HCV RNA titre might be due to a dilution of the virus during washing of the oocytes, removal of the granulosa cells, and refreshing of the media. It is possible to compare the oocyte washing procedure with a selection procedure using a gradient of PureSpermâ, followed by the washing of spermatozoa, from HCV + and HIV + men (Bourlet et al., 2003) . The HCV RNA titre was decreased drastically after the selection and washing of spermatozoa from infected men, and preliminary results have con®rmed an absence of contamination in both the negative female partner and the newborn (Cassuto et al., 2002) . It could therefore be expected that, if the embryo culture media is negative, then the viral risk for viraemic women's embryos is very low and, at most, almost absent. The present results have shown that thorough rinsing of the oocytes and embryos and refreshing of the media appear to be effective and that, as a consequence, all oocytes could be used. None the less, oocytes which were included in a clot of blood and could not be thoroughly washed, must be discarded. Attention must also be paid to the impact of HCV + genital secretions on the contamination rate of the embryo when the transfer is associated with a light cervical bleeding. The risk incurred after the embryo transfer cannot be ignored, and the impact on the offspring contamination rate must be studied in order to evaluate exactly the consequences.
Using serum from an HCV + mother sera for embryo cryopreservation must also be avoided. Consequently, the use of a tested negative serum albumin, or the male partners' serum is recommended.
The viral risk for the laboratory personal is the same as that described in all laboratories. ART does not increase the occupational risk; rather, the strict respect of universal guidelines prevents occupational contamination.
In conclusion, HCV RNA was detected in 89% of FF and 25% of culture media on the day after the ovarian puncture in attempted IVF procedures in HCV + women. Follicular¯uid must be considered as potentially infected. A blood contamination during puncture increases HCV loads in FF. After washing of the oocytes and embryos and refreshing the media, the HCV viral load becomes undetectable, irrespective of the original FF bloody status, and consequently all oocytes can be inseminated. A compartmentalization between the blood and FF in vivo could be invoked, but further studies are required in order to assess the exact impact of ovarian puncture on FF viral status and a possible coupling of the virus with the oocyte and embryo. At present, it is too early to assess the impact of IVF on the mother-to-child transmission rate of HCV, and the follow-up of offspring must be continued. Likewise, there is a need for a prospective study to be conducted on the impact of HCV + genital secretions on transmission rate. Consequently, after counselling HCV + women on the potential risk for the offspring, an IVF attempt is justi®ed. ART procedures do not speci®cally increase the risk to IVF professionals, and strict adherence to universal guidelines can prevent the nosocomial infection of other negative couples and laboratory workers alike.
